help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iwahashi, M.
Right arrow Articles by Nakano, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iwahashi, M.
Right arrow Articles by Nakano, R.
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 7 3346-3350
Copyright © 2001 by The Endocrine Society


Original Articles

Decreased Type III and V Collagen Expression in Chorionic Villi of Hydatidiform Mole

Masaaki Iwahashi, Yasuteru Muragaki, Akira Ooshima and Ryosuke Nakano

Departments of Obstetrics and Gynecology (M.I., R.N.) and Pathology (Y.M., A.O.), Wakayama Medical College, Wakayama 641-0012, Japan

Address all correspondence and requests for reprints to: Masaaki Iwahashi, M.D., Department of Obstetrics and Gynecology, Wakayama Medical College, 811-1 Kimiidera, Wakayama 641-0012, Japan. E-mail: masaaki{at}wakayama-med.ac.jp

Abstract

To investigate the characteristic structure of hydatidiform mole, various types of collagen expression were determined in human villous tissues obtained from normal pregnancies (n = 17) and complete hydatidiform moles (n = 10). Indirect immunofluorescent staining was performed to detect type I, III, and VI collagen with specific monoclonal antibodies. Collagens were also extracted from the villous tissues obtained from normal pregnancy and hydatidiform mole by the salt precipitation method. Immunohistochemical staining for type I, III, and VI collagen revealed weak staining of the villous stroma in hydatidiform mole compared with that in normal pregnancy. Both the ratios of type III to type I collagen and the ratios of type V to type I collagen in the villous tissues were significantly decreased (P < 0.05) in molar pregnancy compared with those in normal pregnancy. These results suggest that alterations in the distribution and composition of collagen might play an important role in determining the pathophysiology and structure of hydatidiform mole.

THE EXTRACELLULAR matrix (ECM) is considered to play an important role in the stability of tissues and in regulating the growth and differentiation of cells (1, 2). Synthesis, accumulation, and catabolism of the ECM occur during wound healing and during the initiation and progression of numerous diseases (3). The ECM of normal villous tissues has been studied (4, 5), but changes in the ECM in the villous tissues of hydatidiform mole are not fully understood.

The hydatidiform mole has such a characteristic macroscopic appearance that it may be diagnosed by the ultrasonographer, attendant at delivery, or the pathologist. Microscopic examination discloses diffuse, marked villous enlargement due to massive stromal edema. The edema displaces the mesenchymal stroma centrally, creating an acellular clear space called a central cistern. There is marked proliferation of cyto- and syncytiotrophoblast (6).

In the present study we investigated the distribution and composition of the various types of collagen, the major component of ECM, in hydatidiform moles by immunofluorescent staining and SDS-PAGE. The results were compared with those obtained during normal pregnancy.

Materials and Methods

This project was approved by the committee on investigations involving human subjects of Wakayama Medical College. Informed consent was obtained from each subject, after the purpose and nature of the study were fully explained.

Tissues

Normal villous tissues were obtained from 17 women, aged 20–38 yr, during early pregnancy (7–12 weeks) by dilatation and curettage for termination of pregnancy and were immediately frozen in liquid nitrogen. Molar tissues were obtained from 10 women, aged 22 to 41 yr, by dilatation and curettage at 7–13 weeks gestation. The pathological diagnosis of all 10 cases was complete hydatidiform mole. We excluded necrotic villous tissue from analysis by histological examination. Gestational age was determined from the date of the last menstrual period and by ultrasonographic measurements performed in early pregnancy.

Primary antibodies

Monoclonal antibodies (mAbs) against each {alpha}1-chain of human type I, III, and VI collagen were used. Preparation of the antibodies was described previously (7). In brief, BALB/c mice were immunized with each type of collagen after it had been extracted from human placentas. The spleen cells of these mice were then hybridized with myeloma cells. After hypoxanthine-aminopterine-thymidine selection, positive hybrids were identified by enzyme-linked immunosorbent assay. The specificity of each antibody was determined by immunoblotting or by inhibition in an enzyme-linked immunosorbent assay. No cross-reaction was recognized among these antibodies.

Immunohistochemistry

Immunohistochemical analysis was performed by the standard indirect immunofluorescence method. In brief, 3-µm frozen sections were rehydrated in PBS at room temperature and then incubated with the primary antibody (diluted 1:100 in PBS) for 12 h at 4 C in a humidified chamber. After incubation, the sections were washed twice in PBS for 3 min each time. Each section was then incubated for 1 h at room temperature with human plasma-preabsorbed, fluorescein isothiocyanate-conjugated goat antibodies against mouse Igs diluted 1:100 in PBS (Organon Teknik Co., West Chester, PA). Subsequently, the sections were washed again in PBS, mounted in buffered glycerol, and examined under a fluorescence microscope (Olympus Corp., Tokyo, Japan).

SDS-PAGE of pepsin-solubilized collagens from the human villous tissues

Minced samples of human villous tissues were washed overnight in cold distilled water and freed of blood. Tissues were homogenized with a Polytron homogenizer (Brinkmann Instruments, Inc., Westbury, NY) in 50 vol 0.5 mol/L acetic acid that contained 1 mg/mL pepsin (Sigma, St. Louis, MO). Collagens were extracted with constant stirring for 24 h at 4 C. Each solution was centrifuged at 39,000 x g for 1 h at 4 C. Collagens were reextracted from the pellet under the same conditions as those described above for 48 h. The supernatants corresponding to individual samples were then combined, and collagens were precipitated by addition of 4.0 mol/L NaCl to a final concentration of 2.0 mol/L. Each precipitate was dissolved in 0.5 mol/L acetic acid, and the solution was dialyzed against 0.02 mol/L Na2HPO4. Precipitated collagens were redissolved in 0.5 mol/L acetic acid, dialyzed exhaustively against 0.05 mol/L acetic acid, and finally lyophilized.

The solubility of the tissue collagen from each villous sample was estimated by comparing the hydroxyproline content of the initial homogenate with that of the final solution of collagen (8). Type V collagen was isolated by salt precipitation from pepsin digests of human villous tissues by the methods described previously (9, 10). The extracted type V collagen was also lyophilized. Estimation of the relative abundance of the {alpha}1(III)-chain and {alpha}1(V)-chain was performed by interrupted gel electrophoresis (11). Electrophoresis was performed in an 8% polyacrylamide slab gel (Sigma). The gel and electrode buffers were 0.1 mol/L phosphate buffer, pH 7.2, containing 0.1% SDS (Nacalai Tesque, Inc., Kyoto, Japan), as previously described (12). Lyophilized samples of collagen and type V collagen were dissolved at a concentration of 0.2 mg/mL and denatured by heating in the gel buffer that contained 1% SDS at 60 C for 30 min. Aliquots of 25 µL of each solution of denatured collagens and 5 µL denatured type V collagen were applied to the gel and subjected to electrophoresis at 80 mA. After 1.5 h the current was switched off, sample wells were filled with a solution of 20% ß-mercaptoethanol (Wako Chemical Co., Osaka, Japan) in gel buffer, and the ß-mercaptoethanol was allowed to diffuse into the gel for 1 h to cleave the intramolecular disulfide bonds of type III collagen, [{alpha}1(III)]3. Then electrophoresis was resumed and allowed to continue for another 1 h. Each collagen {alpha}-chain was stained with Coomassie brilliant blue (Sigma) and quantitated by densitometry. The relative amounts of {alpha}1(III) or {alpha}1(V) chains were calculated by dividing the intensities of bands areas under densitometric peaks of {alpha}1(III) and {alpha}1(V) by that of {alpha}1(I). In this method, the {alpha}-chains derived from type VI collagen could not be evaluated because of degradation of this collagen by pepsin.

Type I collagen content in the human villous tissues

Type I collagen was isolated by salt precipitation from human villous tissues (10 g wet weight) of normal and molar pregnancy by the methods described previously (9, 10). The extracted type I collagen was lyophilized, and we measured the weight of this collagen.

Statistical analysis

Densitometric data and type I collagen weights were expressed as the mean ± SEM. Mean values were compared by Student’s t test or ANOVA using a StatView software program (Abacus Concepts, Inc., Berkeley, CA) on a Macintosh computer (Cupertino, CA). Two-tailed P < 0.05 was considered statistically significant.

Results

Immunohistochemical analysis of the villous tissues

Control sections were stained with goat antibodies against mouse IgG without prior application of the appropriate primary antibody (Figs. 1AGo, 2AGo, and 3AGo). When the mAbs were first allowed to react with an excess of each specific type of collagen, no immunostaining was observed.



View larger version (15K):
[in this window]
[in a new window]
 
Figure 1. Immunofluorescence micrographs of human villous tissues obtained after normal pregnancy and hydatidiform mole with immunostaining by a mAb specific for type I collagen. No immunofluorescence is recognized in the control section (A). Strong immunofluorescence specific for type I collagen is diffusely distributed in the stroma of the villous tissues in normal pregnancy (B). However, weak and fragmented immunofluorescence was seen in the stroma of villi in molar pregnancy (C). Original magnification, x125.

 


View larger version (19K):
[in this window]
[in a new window]
 
Figure 2. Immunofluorescence micrographs of human villous tissues obtained after normal pregnancy and hydatidiform mole with immunostaining by a mAb specific for type III collagen. No immunofluorescence is recognized in the control section (A). Strong immunofluorescence specific for type III collagen is diffusely distributed in the stroma of the villous tissues in normal pregnancy (B). However, weak and fragmented immunofluorescence was seen in the stroma of the villous tissues in molar pregnancy (C). Original magnification, x125.

 


View larger version (17K):
[in this window]
[in a new window]
 
Figure 3. Immunofluorescence micrographs of human villous tissues obtained after normal pregnancy and hydatidiform mole with immunostaining by a mAb specific for type VI collagen. No immunofluorescence is recognized in the control section (A). Strong immunofluorescence specific for type VI collagen is diffusely distributed in the stroma of the villous tissues with microfibrally pattern in normal pregnancy (B). However, weak and fragmented immunofluorescence was seen in the stroma of the villous tissues in molar pregnancy (C). Original magnification, x125.

 
Immunostaining with the mAbs against type I (Fig. 1BGo) and type III (Fig. 2BGo) collagen showed a fibrillary pattern in the villous stroma in normal pregnancy. However, immunostaining for these types of collagen showed a weak and fragmented pattern in the villous stroma in molar pregnancy (Figs. 1CGo and 2CGo).

Immunostaining with the mAbs against type VI collagen showed a microfibrillary pattern in the villous stroma in normal pregnancy (Fig. 3BGo). However, immunostaining for this collagen showed a weak and fragmented pattern in the villous stroma in molar pregnancy (Fig. 3CGo). The intensity of staining of the villous tissues from normal pregnancy and complete mole by each of the antibodies against various types of collagen was subjectively graded from 1+ to 3+, and the results are summarized in Table 1Go.


View this table:
[in this window]
[in a new window]
 
Table 1. Immunostaining with antibodies for type I, III, and VI collagens in villous tissues from normal pregnancy and molar pregnancy

 
SDS-PAGE of pepsin-solubilized collagens from the human villous tissues

Although the relative levels of {alpha}1(I) were similar in the villous tissues obtained from normal pregnancy and hydatidiform mole, those of {alpha}1(V) and those of {alpha}1(III) decreased in the villous tissues of hydatidiform mole compared with those of normal pregnancy (Fig. 4Go). The data are summarized in Table 2Go. The mean ratio of the intensity of the band of {alpha}1(III) to that of {alpha}1(I) in villous tissues of hydatidiform mole was significantly lower than that in villous tissues of normal pregnancy (P < 0.05). Moreover, the mean ratio of the intensity of the band of {alpha}1(V) to that of {alpha}1(I) in villous tissues of hydatidiform mole was significantly lower than that in villous tissues of normal pregnancy (P < 0.01).



View larger version (74K):
[in this window]
[in a new window]
 
Figure 4. SDS-PAGE of pepsin-solubilized collagens from the villous tissues of normal pregnancy (lane 1), hydatidiform mole (lane 2), and type V collagen extracted from the decidual tissues (lane 3). Samples of heat-denatured collagen (5 mg, lanes 1 and 2; 1.0 µg, lane 3) were subjected to electrophoresis on a slab gel for 1 h. After reduction in situ with ß-mercaptoethanol for 30 min, electrophoresis was resumed for 1 h. In this study the {alpha}-chains derived from type IV collagen could not be detected because of their low level in the sample, and the {alpha}-chains derived from type VI collagen could not be evaluated because of degradation of this collagen by pepsin. Note that the type V collagen obtained from villous tissue by differential salt precipitation was composed predominantly of the {alpha}1(V)-chain.

 

View this table:
[in this window]
[in a new window]
 
Table 2. Relative abundance of the {alpha}1(III) and {alpha}1(V) chains of collagen compared with the {alpha}1(I) chain in the villous tissues obtained from normal pregnancy and molar pregnancy

 
Type I collagen content in the human villous tissues

Type I collagen content in villous tissues of hydatidiform mole was significantly lower than that in villous tissues of normal pregnancy (8.9 ± 2.5 vs. 19.2 ± 4.3 mg; P < 0.01).

Discussion

In the present study we investigated changes in the distribution and composition of the ECM, including type I, III, V, and VI collagens, in the human villous tissues obtained normal pregnancy and hydatidiform mole. We were able to solubilize 70–85% of collagen in the human villous and molar tissues, as measured by reference to levels of hydroxyproline (data not shown). Therefore, it was postulated that the extracted collagen might accurately reflect the entire complement of collagen in the tissues.

The decreased expression of interstitial collagens, such as type I, III, and VI collagens, was confirmed immunohistochemically in the villi of hydatidiform mole compared with those of normal pregnancy. Moreover, the type I collagen content in the villous tissues of hydatidiform mole was significantly lower than that in villous tissues of normal pregnancy. This finding was consistent with the immunohistochemical results. However, the relative level of type I collagen in the total collagen extracted from the villous tissues was similar in normal and molar pregnancy.

Although type I and type III collagens are commonly found in combination, the ratio of type III or type V to type I collagen in the tissues of hydatidiform mole was significantly lower than that in normal pregnancy. Changes in the ratio of type III to type I collagen have been demonstrated in human skin (11) and in human atherosclerosis (13, 14). A possible cause might be an alteration in the density of cells in the human villous tissues. Recently, cell density-dependent effects have been reported in the various types of cell, such as mesangial cells (15, 16), endothelial cells (17, 18), vascular smooth muscle cells (19, 20), fibroblasts (21, 22), and primitive mesenchymal cells (23). It has been suggested that cell density might modulate biological behavior, with changes in signal transduction responses to hormonal stimulation, in growth, in the synthesis and composition of the ECM, and in the synthesis of specific proteins (15, 16). Wolthuis et al. (16) reported that mesangial cells synthesized relatively more type I collagen per cell at higher cell densities, whereas synthesis of type III and type IV collagens in each cell did not depend on cell density. Therefore, it is suggested that hydatidiform mole might show intense proliferation of the trophoblastic cells, and that at higher cell densities these cells might synthesize relatively more type I collagen than the other collagen.

Type V collagen was originally described as a component of chorionic and amniotic membranes (24). It is thought to play a major role in maintaining a barrier against pathogens and inflammatory cells and in preventing the loss of amniotic fluid (25). Type V collagen has the ability to bind to insulin (26) and heparin/heparan sulfate (27) with apparently higher affinity than collagen types I, II, III, IV, or VI; fibronectin; or laminin. Yaoi et al. (26) indicated that insulin bound to type V collagen retains mitogenic activity and that heparin/heparan sulfate modulates the biological activities of vascular endothelial cell growth factor (28) and basic fibroblast growth factor (29, 30). These findings suggest that type V collagen might be important in the compartmentalization, storage, stabilization, and modulation of the activities of various growth factors. As type V collagen also binds to thrombospondin (31), the interactions of this collagen with thrombospondin and heparan sulfate may be important in the assembly of the ECM and in the regulation of its biological functions. In addition, this collagen has been shown to mediate the behaviors of cells, including their attachment, spread proliferation, and morphogenesis (32, 33). Therefore, it is suggested that decreased relative levels of {alpha}1(V) or type V collagen in the villi might provide a biochemical basis for functional regulation of the trophoblast cells of hydatidiform mole. It has also been postulated that trophoblast invasion might be modulated by interactions between the ECM receptors on the surface of trophoblast cells and the corresponding ligands (34, 35). Thus, a reduction of type V collagen in the villi might result in reduced attachment or increased metastatic ability of trophoblast cells in hydatidiform moles.

In conclusion, decreased interstitial collagens, including type I, III, V, and VI collagens, were found in the stroma of the villi in hydatidiform moles. Therefore, these alterations in the distribution and the composition of collagens might result in the morphological and functional characteristics of hydatidiform mole.

This study provides some clues to understanding the pathophysiology of hydatidiform mole in terms of the ECM metabolism. Further work is needed to elucidate the mechanisms regulating the trophoblastic expression of genes for other types of collagen in normal pregnancy and hydatidiform mole.

Received April 4, 2000.

Revised October 4, 2000.

Revised March 20, 2001.

Accepted March 25, 2001.

References

  1. Lin CQ, Bissell MJ. 1993 Multi-faceted regulation of cell differentiation by extracellular matrix. FASEB J. 7:737–743.[Abstract]
  2. Madri JA, Basson MD. 1992 Extracellular matrix-cell interactions: dynamic modulators of cell, tissue and organism structure and function. Lab Invest. 66:519–521.[Medline]
  3. Haralson MA. 1993 Extracellular matrix and growth factors: an integrated interplay controlling tissue repair and progression to disease. Lab Invest. 69:369–372.[Medline]
  4. Blankenship TN, Enders AC, King BF. 1992 Distribution of laminin, type IV collagen, and fibronectin in the cell columns and trophoblastic shell of early macaque placentas. Cell Tissue Res. 270:241–248.[CrossRef][Medline]
  5. Nanaev AK, Milovanov AP, Domogatsky SP. 1993 Immunohistochemical localization of extracellular matrix in perivillous fibrioid of normal human term placenta. Histochemistry. 100:341–346.[CrossRef][Medline]
  6. Lage JM. 1994 The placenta. In: Gompel C, Silverberg SG. eds. Pathology in gynecology, 4th Ed. Philadelphia: Lippincott; 448–512.
  7. Ooshima A, Muragaki Y. 1990 Collagen metabolism in atherogenesis. Ann NY Acad Sci. 598:582–584.[CrossRef][Medline]
  8. Kivirikko KI, Prockop DJ. 1967 Hydroxylation of proline in synthetic polypeptides with purified protocollagen hydroxylase. J Biol Chem. 242:4009–4012.
  9. Furuto DK, Miller EJ. 1980 Isolation of a unique collagenous fraction from limited pepsin digests of human placental tissue. J Biol Chem. 255:290–295.[Abstract/Free Full Text]
  10. Miller EJ, Rhodes RK. 1982 Preparation and characterization of the different types of collagen. Methods Enzymol. 82:33–64.
  11. Sykes B, Puddle B, Francis M, Smith R. 1976 The estimation of two collagen from human dermis by interrupted gel electrophoresis. Biochem Biophys Res Commun. 72:1472–1480.[CrossRef][Medline]
  12. Laemmli UK. 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680–685.[CrossRef][Medline]
  13. McCullagh KA, Balian G. 1975 Collagen characterisation and cell transformation in human atherosclerosis. Nature. 258:73–75.
  14. Ooshima A. 1981 Collagen {alpha} B chain: increased proportion in human atherosclerosis. Science. 213:666–668.[Abstract/Free Full Text]
  15. Ishimura E, Sterzel RB, Budde K, Kashgarian M. 1989 Formation of extracellular matrix by cultured rat mesangial cells. Am J Pathol. 134:843–855.[Abstract]
  16. Worthuis A, Boes A, Grond J. 1993 Cell density modulates growth, extracellular matrix, and protein synthesis of cultured rat mesangial cells. Am J Pathol. 143:1209–1219.[Abstract]
  17. Patton WF, Yoon MU, Alexander JS, et al. 1990 Expression of simple epithelial cytokeratins in bovine pulmonary microvascular endothelial cells. J Cell Physiol. 143:140–149.[CrossRef][Medline]
  18. Orpana A, Ranta V, Mikkola T, Viinikka L, Ylikorkala O. 1997 Inducible nitric oxide and prostacyclin productions are differently controlled by extracellular matrix and cell density in human vascular endothelial cells. J Cell Biochem. 64:538–546.[CrossRef][Medline]
  19. Goodman LV, Majack RA. 1989 Vascular smooth muscle cells express distinct transforming growth factor-ß receptor phenotypes as a function of cell density in culture. J Biol Chem. 264:5251–5244.
  20. Kato S, Shanley JR, Fox JC. 1996 Serum stimulation, cell-cell interactions, and extracellular matrix independently influence smooth muscle cell phenotype in vitro. Am J Pathol. 149:687–697.[Abstract]
  21. Ellis IR, Schor SL. 1996 Differential effects of TGF-beta 1 on hyaluronan synthesis by fetal and adult skin fibroblasts: implications for cell migration and wound healing. Exp Cell Res. 228:326–333.[CrossRef][Medline]
  22. Brenn T, Aoyama T, Francke U, Furthmayr H. 1996 Dermal fibroblast culture as a model system for studies of fibrillin assembly and pathogenetic mechanisms: defects in distinct groups of individuals with Marfan’s syndrome. Lab Invest. 75:389–402.[Medline]
  23. Tsonis PA, Goetinck PK. 1990 Cell density effects of a tumor promotor on proliferation and chondrogenesis of limb bud mesenchymal cells. Exp Cell Res. 190:247–253.[CrossRef][Medline]
  24. Burgeson RE, El Adri FA, Kaitila II, Hollister DW. 1976 Fetal membrane collagens: identification of two new collagen {alpha} chains. Proc Natl Acad Sci USA. 73:2379–2383.[Abstract/Free Full Text]
  25. Modesti A, Kalebic T, Scarpa S, et al. 1984 Type V collagen in human amnion is a 12-nm fibrillar component of the pericellular interstitium. Eur J Cell Biol.35:246–255.
  26. Yaoi Y, Hashimoto K, Takahara K, Kato I. 1991 Insulin binds to type V collagen with retention of mitogenic activity. Exp Cell Res. 194:180–185.[CrossRef][Medline]
  27. Richard GL, Agneta H, Jeffrey DE, Steffen G, Magnus H. 1989 Binding of heparan sulfate to type V collagen. J Biol Chem. 264:7950–7956.[Abstract/Free Full Text]
  28. Lobb RR, Harper JW, Fett JW. 1986 Purification of heparin-binding growth factors. Anal Biochem. 154:1–14.[CrossRef][Medline]
  29. Thornton SC, Mueller SN, Levine EM. 1983 Human endothelial cells: use of heparin in cloning and long-term serial cultivation. Science. 222:623–625.[Abstract/Free Full Text]
  30. Schreiber AB, Kenny J, Koalski WJ, et al. 1985 Interaction of endothelial cell growth factor with heparin: characterization by receptor and antibody recognition. Proc Natl Acad Sci USA. 82:6138–6142.[Abstract/Free Full Text]
  31. Mumby SM, Rauji GJ, Bornstein P. 1984 Interactions of thrombospondins with extracellular matrix proteins: selective binding to type V collagen. J Cell Biol. 98:646–652.[Abstract/Free Full Text]
  32. Fukuda K, Koshihara Y, Oda H, Ohyama M, Ooyama T. 1988 Type V collagen selectively inhibits human endothelial cell proliferation. Biochem Biophys Res Commun. 151:1060–1068.[CrossRef][Medline]
  33. Sakata N, Jimi S, Takebayashi S, Marques MA. 1992 Type V collagen represses the attachment, spread and growth of porcine vascular smooth muscle cells in vivo. Exp Mol Pathol. 56:20–36.[CrossRef][Medline]
  34. Korhonen M, Ylanne J, Laitinen L, et al. 1991 Distribution of the {alpha}1-{alpha}6 integrin subunits in human developing and term placenta. Lab Invest. 65:347–356.[Medline]
  35. Damsky CH, Fitzgerald ML, Fisher SJ. 1992 Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vitro. J Clin Invest. 89:210–222.




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iwahashi, M.
Right arrow Articles by Nakano, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iwahashi, M.
Right arrow Articles by Nakano, R.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals